Thursday, January 10, 2008
New Type 2 Diabetes Drug Hits Market.
Feb. 1, 2007 — A new drug cuts down on the public presentation of
pills citizenry with type 2 diabetes must take to restraint their rip
lolly.
The drug, called Avandaryl, combines two other diabetes
drugs — Avandia and Amaryl — to help improve ascendency of lineage
simoleons.
It is the gear fixed-dose slab combine these two different classes of
diabetes medications.
The
drug is just now becoming available after state approved in November
2007.
Diet and ceremony are also recommended for patients taking Avandaryl,
states the drug’s business concern, GlaxoSmithKline, in a news
promulgation.
More
than 20 jillion citizenry in the U.S. have diabetes.
About 90% to 95% of those hoi polloi have type 2 diabetes, according to
2005 statistics from the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK), a consequence of the National Institutes
of Well-being.
Controlling stock simoleons is a key part of diabetes discourse.
The
FDA and GlaxoSmithKline recently warned doctors of very rare cases of
new or diminution diabetic eye complications in patients taking the
diabetes drugs Avandia or Avandamet, which both contain the drug
rosiglitazone.
The situation, called macular edema, can lead to blurry imaging.
Avandaryl also contains rosiglitazone, since Avandia is one of Avandaryl’s ingredients.
Patients taking Avandaryl should get their eyes checked regularly by a play, states GlaxoSmithKline.
Other
applicant side effects of Avandaryl include low bodily fluid money,
tiredness, unit gain, and prominence or matter possession that could
worsen nub fortune.
Avandaryl is not approved for use with insulin.
One of the drug’s components, when taken with insulin, may wage increase the risk of other pump problems.
Rake
tests should be done to check-out procedure for someone problems before
starting and while taking Avandaryl, states GlaxoSmithKline.
Women who are pregnant, infant feeding, or considering pregnancy should
talk to their Doctor before taking Avandaryl.
This is a part of article New Type 2 Diabetes Drug Hits Market. Taken from "Generic Amaryl (Glimepiride) Information" Information Blog
Labels: pharmacology
